Over 90 Total Lots Up For Auction at One Location - WA 04/08

Stanford University Medical Center to acquire second Accuray CyberKnife M6 system

Press releases may be edited for formatting or style | December 04, 2019 Rad Oncology
SUNNYVALE, Calif., Dec. 4, 2019 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Stanford University Medical Center has selected a second CyberKnife® M6™ System to expand access to precise radiosurgery treatments to more of their patients. With its installation, the hospital's clinicians will have a CyberKnife System dedicated to the treatment of diseases in the brain and base of the skull, making it possible for the existing system to be used to treat more patients with tumors elsewhere in the body. The new CyberKnife System will be installed at the Stanford Neuroscience Health Center, a comprehensive facility offering integrated outpatient services in one location designed to provide more accurate diagnoses, organized care, better quality of life and improved outcomes for the patient.

"We value our long-standing partnership with the Stanford clinical team, one of the most respected in the world, and are proud that they are using the CyberKnife System to improve the outcomes of people diagnosed with serious medical conditions," said Joshua H. Levine, president and CEO at Accuray. "At Accuray, our goal is to provide clinicians with a system that makes it as easy as possible for them to provide the best possible outcome for their patients, based on each patient's unique condition. Over the course of our relationship with the Stanford team, they have acquired four CyberKnife Systems, reinforcing their continued confidence in the system and demonstrating that we are delivering on our goal."

"This year marks 25 years since the world's first patient was treated with a prototype CyberKnife System at Stanford. While clinicians at our hospital have used some version of the system since that time, a dedicated system located in our neuroscience center will enable us to provide precise and accurate SRS treatments to significantly more patients," said Steven D. Chang, MD, Co-Director, Stanford Surgical Neuro-Oncology Program, Co-Director, Stanford CyberKnife Program, Stanford University School of Medicine. "The introduction of the CyberKnife System changed the way diseases or tumors in the head are treated. The system established multi-session or fractionated treatment as a standard for cranial stereotactic radiosurgery, a technique that has brought meaningful benefits to patients and the medical field."

The CyberKnife System was designed to deliver stereotactic radiosurgery (SRS) without a rigid frame bolted to the patient's head, which some other systems use to prevent movement during treatment. It provides a precise and effective option for patients with diseases or tumors in the brain requiring single or multi-session treatments, and younger patients who would not be candidates for treatment with a fixed head frame. Since its introduction, advanced new functionality, including the VOLO™ Optimizer, has been added to the CyberKnife System, enabling clinicians to treat patients significantly faster, without sacrificing the precision or accuracy for which the system is known.

You Must Be Logged In To Post A Comment